The United States (U.S.) Foreign Corrupt Practices Act (FCPA), which came into being in 1977, “prohibits bribery of foreign officials by individuals and companies with a U.S. nexus to obtain business advantages.”[1] It was enacted in following investigations into bribery of Asian and European officials by companies such as Lockheed…
Shein, Temu, and other Chinese online retailers like AliExpress (part of Alibaba Group) are a consumer’s dream. They give American, European, and other buyers access to an immense array of low-cost goods, a particularly appealing feature at a time when many are stressed by the rising cost of living. Politicians,…
Intel’s relationship with the United States (US) government since 2021 has experienced considerable ebbs and flows, though it seems to be on a high lately, obtaining a major investment from the US government as well as a slew of high-profile, major investments from leading high-tech firms like Nvidia. These public…
Apple has been a great success story in no small part because of China. China has been a huge market for United States (US) based smartphone giant (one of its largest markets along with the US), a key cog in its massive global supply chain, and a source of technology…
In fall 2024, the BIOSECURE Act, which blocked the United States (US)’s government’s use of goods and services from Chinese biotech companies, sailed through the US House of Representatives only to become stalled in the US Senate.[1] This is only one in a series of US government (USG) efforts to…
On September 9, the BIOSECURE Act, which this blog series has been covering since March, passed by a huge majority in the United States (US) House of Representatives. The essence of the act is the termination of direct and indirect US government dealings with five Chinese biotech companies (Complete Genomics,…
The most recent and prominent United States (US) attempt to limit cooperation with Chinese life science businesses has stalled, but is hardly dead. Current Speaker of the House Mike Johnson said he intends to have the BIOSECURE Act signed into law before the end of 2024.[1] Irrespective of the impasse,…
In January 2024, Congressman Mike Gallagher, the Chair of the United States (US) House Committee on the Chinese Communist Party, introduced the “Biosecure Act,” which prohibits the US government (USG) from “procuring or obtaining biotechnology equipment or services produced or provided by a biotechnology company of concern,” participating in a…
The Belt and Road Initiative (BRI) has generated so much commentary that it is conceivable that if one printed out all the relevant pages and laid them end-to-end the length might approach that of all the railway track laid under the aegis of the BRI![i] Further commentary seems even more…
China, as you would expect, Belt and Road Initiative (BRI) participants and proponents, and even data support some of the positive sentiment in, if not the logic of, the previous blog in this four-part series on the future of the BRI, which highlighted numerous factors likely to continue propelling the…
